NOV's 2027 Offshore Story Meets a 2026 Book-to-Bill Cut

NOV's 2027 Offshore Story Meets a 2026 Book-to-Bill Cut

NOV delivered a respectable third quarter — $2.23 billion of revenue, $281 million of adjusted EBITDA, and a 12.6% EBITDA margin — but the stock has not been re-rated. The shares are roughly flat over the past 90 days and still sit about 78% below their 2014 peak. That is the right backdrop for this call: a company with a genuinely improving operating story that the market is treating as a “show-me” situation until orders and cash flow confirm it.

The tell was in the order book. Management had previously framed 2026 book-to-bill around 1x; on this call, CFO Rodney Reed and CEO Jose Bayardo effectively walked that back. Bayardo said the prior 90%-to-100% range now looks “probably a little bit ambitious” and guided to a full-year book-to-bill of 80% to 85%.

the best estimate right now is that we will finish the year at the book-to-bill of between call it, 80% to 85%

The 2027 pitch is louder — and more specific

The bull case rests on offshore project sanctioning. NOV says offshore FIDs in 2026 and 2027 should exceed 2024-2025 by roughly 50%, and because equipment orders typically lag FIDs by a few quarters, the company expects 2027 bookings to “meaningfully exceed” 2026 and 2025. That is a more concrete version of the “all eight cylinders” argument management made in April. Back then, Bayardo said: “Late this year and into 2027, we could finally be in that environment where all eight cylinders of NOV Inc.’s engine can fire” — Jose A. Bayardo, Chairman, President and CEO · 2026-04-28 The difference now is that management is putting numbers around it — and leaning harder on the aftermarket business as the near-term bridge.

That aftermarket signal is the most tangible positive in the quarter. Spare-parts backlog rose in the high teens year over year and has now increased for five consecutive quarters. Bayardo also highlighted record drill-bit results, record motor revenue in downhole tools, and a fifth straight year of margin improvement in Energy Equipment. The offshore production pipeline is similarly specific: deeper water, more gas handling, harsher environments, and larger FPSO scopes play to NOV’s flexible-pipe, gas-processing, and turret-mooring franchise. The offshore FIDs pipeline is why management says it has “growing confidence” in a multiyear production-equipment opportunity.

International unconventionals add a second leg. Argentina’s Vaca Muerta has now grown double digits year over year for three consecutive quarters, and NOV booked production and midstream equipment orders tied to natural-gas infrastructure there. Management also cited Algeria, Australia, Egypt, and Pakistan as emerging unconventional markets, with Venezuela small but growing quickly. This is not a new theme — prior calls discussed international shale repeatedly — but it is becoming a cleaner, more quantifiable part of the growth story.

Cash flow is the credibility gap

The problem is that the income statement is ahead of the cash flow statement. Q3 free cash flow was a $47 million use of cash; the last filed quarter showed a similar pattern. Free cash flow less stock-based compensation was -$79 million in the last reported quarter, and the Q3 call put it at -$47 million. Rodney attributed the weakness to two discrete items: milestone billings delayed by Middle East logistics, and higher inventory buffers held to protect against supply-chain disruption. He called both “more transitory than structural” and guided to a return to roughly 50% EBITDA-to-free-cash-flow conversion in 2027.

That is a pushout. On the February call, management was framing 2026 conversion in the 40%-50% range; now the cleaner 50% target is a 2027 event. The balance sheet is not stretched — effective net cash was -$556 million — but investors have heard “transitory” working-capital stories before. The next two quarters need to show milestone collections improving and inventory normalizing, or the 2027 earnings-power narrative will remain theoretical.

What changed — and what did not

The Middle East is the swing factor. Earlier this year, the region was the central risk; now management is trying to frame growth ex Middle East. Bayardo said the region should be down mid-single digits in Q4 as rigs are suspended and customers adjust drilling programs. “we expect The Middle East to be down in the mid single digit range for Q4” — Jose A. Bayardo, Chairman, President and CEO · 2026-10-28 That is a meaningful headwind for a business that has leaned on Saudi rig manufacturing and regional production equipment. The offset is that other international markets — Vaca Muerta, offshore Brazil, Africa, Asia — are improving enough to keep the consolidated story intact.

Pricing is the other unresolved thread. Management believes the equipment market is near a tipping point after years of underinvestment. “I think we are nearing a point where excess supply of the type of desirable equipment that is out there is at its limit” — Jose A. Bayardo, Chairman, President and CEO · 2026-10-28 If that is right, 2027 could bring both higher aftermarket volume and price. The $1.5 billion EBITDA target does not require heroic assumptions: Bayardo framed it as roughly $100 million from rig aftermarket recovery, $120 million from restoring Energy Products & Services margins toward 17.5%, and the balance from modest volume and efficiency gains. “If we are able to drive that up 300 basis points back up to 17 and a half, percent... that is another $120 million of EBITDA” — Jose A. Bayardo, Chairman, President and CEO · 2026-10-28 That is a credible bridge — but it is still a bridge, not a current run rate.

For now, NOV is a company whose 2027 story is getting stronger while its 2026 order book is getting softer. The market has noticed the former but is waiting on the latter. If the aftermarket backlog keeps building and offshore FIDs convert into bookings in the first half of 2027, the compressed-spring analogy may finally have a catalyst. Until then, the stock is likely to trade on quarterly book-to-bill and cash conversion — not on the promise of $1.5 billion of EBITDA.